Go Pro
NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Price, News & Analysis

Rockwell Medical logo
$8.06 +0.15 (+1.90%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$7.95 -0.11 (-1.34%)
As of 09/18/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Rockwell Medical Stock (NASDAQ:RMTI)

Advanced

Key Stats

Today's Range
$7.50
$8.23
50-Day Range
$5.63
$8.31
52-Week Range
$4.89
$14.10
Volume
44,476 shs
Average Volume
20,044 shs
Market Capitalization
$32.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00
Consensus Rating
Hold

Company Overview

Rockwell Medical, Inc. is a healthcare company focused on products used in the treatment of patients with end-stage renal disease who receive hemodialysis. The company develops, manufactures and distributes hemodialysis concentrates, including acid and bicarbonate products used to prepare dialysate, the fluid that helps remove waste and excess fluid from the blood during treatment.

Rockwell Medical’s product portfolio also includes Triferic, an iron-replacement therapy based on ferric pyrophosphate citrate. Triferic is designed to deliver iron to adult hemodialysis patients during treatment and is available in formulations intended for use with different dialysis systems. The company markets its products primarily to dialysis providers and healthcare organizations.

Founded in 1996, Rockwell Medical is headquartered in Wixom, Michigan. Its operations have historically centered on serving the U.S. dialysis market, while the company has also pursued opportunities to expand the availability of its products through international and strategic commercial relationships.

AI Generated. May Contain Errors.

Rockwell Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

RMTI MarketRank™: 

Rockwell Medical scored higher than 45% of companies evaluated by MarketBeat, and ranked 559th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Rockwell Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Rockwell Medical has a consensus price target of $20.00, representing about 148.1% upside from its current price of $8.06.

  • Amount of Analyst Coverage

    Rockwell Medical has only been the subject of 2 research reports in the past 90 days.

  • Read more about Rockwell Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Rockwell Medical are expected to grow in the coming year, from ($0.90) to $0.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rockwell Medical is -6.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rockwell Medical is -6.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Rockwell Medical has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Rockwell Medical's valuation and earnings.
  • Percentage of Shares Shorted

    2.42% of the float of Rockwell Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Rockwell Medical has a short interest ratio ("days to cover") of 3.42, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Rockwell Medical has recently increased by 5.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Rockwell Medical does not currently pay a dividend.

  • Dividend Growth

    Rockwell Medical does not have a long track record of dividend growth.

  • News Sentiment

    Rockwell Medical has a news sentiment score of -0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Rockwell Medical this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Rockwell Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    4.60% of the stock of Rockwell Medical is held by insiders.

  • Percentage Held by Institutions

    23.31% of the stock of Rockwell Medical is held by institutions.

  • Read more about Rockwell Medical's insider trading history.
Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RMTI Stock News Headlines

FY2026 EPS Forecast for Rockwell Medical Reduced by Analyst
HC Wainwright Cuts Earnings Estimates for Rockwell Medical
Elon Musk’s Hushed FCC Filing. Sept 25th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel
Rockwell Medical (NASDAQ:RMTI) Earns "Buy" Rating from HC Wainwright
Rockwell Medical (RMTI) Q2 2026 Earnings Call Transcript
See More Headlines

RMTI Stock Analysis - Frequently Asked Questions

Rockwell Medical's stock was trading at $8.3350 on January 1st, 2026. Since then, RMTI stock has decreased by 3.3% and is now trading at $8.06.

Rockwell Medical, Inc. (NASDAQ:RMTI) posted its earnings results on Thursday, August, 13th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.11. The business had revenue of $17.78 million for the quarter, compared to analyst estimates of $17.82 million. Rockwell Medical had a negative net margin of 7.33% and a negative trailing twelve-month return on equity of 14.03%.
Read the conference call transcript
.

Rockwell Medical's stock reverse split on the morning of Wednesday, July 1st 2026.The 1-10 reverse split was announced on Monday, June 29th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Axcelis Technologies (ACLS), Opera (OPRA), ADMA Biologics (ADMA), ASML (ASML) and InterDigital (IDCC).

Company Calendar

Last Earnings
8/13/2026
Today
9/20/2026
Next Earnings (Estimated)
11/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:RMTI
CIK
1041024
Employees
157
Year Founded
1995

Price Target and Rating

High Price Target
$20.00
Low Price Target
$20.00
Potential Upside/Downside
+148.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.31 million
Net Margins
-7.33%
Pretax Margin
-7.33%
Return on Equity
-14.03%
Return on Assets
-8.90%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
3.25
Quick Ratio
3.00

Sales & Book Value

Annual Sales
$69.26 million
Price / Sales
0.47
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.38 per share
Price / Book
0.86

Miscellaneous

Outstanding Shares
4,030,000
Free Float
3,845,000
Market Cap
$32.48 million
Optionable
Optionable
Beta
1.64

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:RMTI) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners